Background: Facilities serving vulnerable women have higher false-positive rates for diagnostic mammography than facilities serving nonvulnerable women. False positives lead to anxiety, unnecessary biopsies, and higher costs.
T here is significant variability in diagnostic mammography interpretative performance. [1] [2] [3] One in 15 diagnostic mammograms in the United States yields a false positive, a recommendation for biopsy in a woman without cancer. 4 False positives lead to anxiety, unnecessary biopsies, and increased health care costs. 5 Mammography facilities that serve vulnerable women, defined as women with limited income, education, racial/ethnic minorities, or women who live in rural areas, have a 2%-3% (absolute) higher false-positive rate for diagnostic mammography than facilities that serve nonvulnerable women. 6 This represents a 33% relative increase in false positives. The underlying reason for this disparity is unknown.
Characteristics of both women and radiologists can influence diagnostic mammography false-positive rates. 4 Few studies have evaluated the impact of facility characteristics on false positives. 1, 3, 7 Slightly higher diagnostic mammography false-positive rates (and sensitivities) are seen at academic centers. 4 The use of breast ultrasound is associated with lower false-positive rates in screening mammography. No studies have investigated whether facility characteristics explain the higher false-positive rates at facilities serving vulnerable women. Facility characteristics such as on-site biopsy or for-profit ownership could represent incentives to increase biopsy referral rates, and thereby influence false-positive rates.
We analyzed whether the availability of on-site ultrasound or biopsy, academic affiliation, or profit status accounted for the higher false-positive rates at facilities serving predominately vulnerable women in a national cohort of women undergoing diagnostic mammography.
METHODS
Data were pooled from mammography registries in 7 states participating in the National Cancer Institute-funded Breast Cancer Surveillance Consortium (BCSC), shown to be representative of the US women undergoing mammography. 8 The registries prospectively collect women's self-reported demographic and clinical data at each mammography examination, together with radiologists' mammography interpretations. Registries ascertain cancer outcomes through linkage with state tumor registries, regional Surveillance, Epidemiology, and End Results programs, and pathology databases. In addition, the BCSC collects characteristics of facilities where women underwent mammography. Each registry received approval from institutional review board to enroll participants, link data, and perform analysis. All procedures are compliant with Health Insurance Portability and Accountability Act.
We included examinations from 1999 to 2005 identified by the radiologist as performed for "evaluation of a symptomatic breast problem" on women 40-80 years of age. We excluded examinations from women with a prior diagnosis of breast cancer or history of breast augmentation, missing from the time since her previous mammogram, missing a valid Breast Imaging Reporting and Data System final mammography assessment or breast density, 9, 10 or examinations performed at a facility with unknown or incomplete vulnerability or facility characteristics.
We classified positive and negative diagnostic examinations by standard BCSC criteria. 11 Women had a diagnosis of breast cancer if reports from the cancer sources showed invasive carcinoma or ductal carcinoma in situ within 12 months of the diagnostic exam. We calculated the sensitivity, false-positive rate, and cancer detection rate using standard BCSC definitions to evaluate diagnostic mammography interpretive performance. 11 We defined vulnerable women by 4 socio-demographic measures: educational attainment, race/ethnicity, residence in rural/urban area, and household income. 6, 12 Self-reported information was used to determine educational attainment and race/ethnicity. Geocoded linkages between 2000-census data and each woman's self-reported ZIP code were used to determine median household income and percent of rural residences within the ZIP code. To describe the vulnerability of the population served by each facility, we aggregated the patient characteristics for the 4 vulnerability measures across all mammography examinations (both screening and *Composite vulnerability scores were calculated by adding 1 for each of the following vulnerability indexes met: education: <83% of the facility population completed high school; race/ethnicity: >30% of the facility population are minorities; rural/urban residence: average percentage of rural residences among the facility population is >52%; and income: average median household income among the facility population is <$45,000. diagnostic) served by the facility from 1999 to 2005. For each facility we measured (1) the percentage of the population with at least a high school education; (2) the percentage of the population composed of minorities (self-reported African American race, or Hispanic/Pacific-Islander/Hawaiian/ Native American ethnicity); (3) the average median household income; and (4) the average percentage of rural residents. Facilities were assigned a binary indicator of whether they served a vulnerable population (for each of the 4 categories) based on prior developed cutoffs: if (1) >17% of mammography interpretations were from women who had not completed high school (lower educational attainment); (2) the percentage minority was >30% (racial/ethnic minority); (3) the average median income was <$45,000 (limited income); or (4) the average percentage of rural residences was >52% (rural residence). 13 We constructed a composite vulnerability score by adding 1 for each of the binary vulnerability indexes met. 12 We considered 4 explanatory variables to account for the association between vulnerability and diagnostic falsepositive rates: whether a facility had breast ultrasound available; availability of on-site biopsy services; academic medical center affiliation; and profit status.
Analysis
We described the distribution of mammography level and facility level characteristics across vulnerability categories, and calculated unadjusted sensitivity, false-positive rates, and cancer detection rates for each vulnerability index. We fit separate logistic-normal mixed effects models 14 with mammography as the unit of analysis for each of the 4 vulnerability indexes (and the composite score) to estimate adjusted odds ratios (OR) and 95% confidence intervals (CI) between each facet of facility-level vulnerability and mammography-level performance (sensitivity, false-positive rate, cancer detection rate), adjusted for patient-level covariates only (study site, age, time since previous mammography, and Breast Imaging Reporting and Data System breast density 1 ), and incorporated facility-level random effects to account for clustering of examinations within the facility. Because we found significant associations (P < 0.05) between most vulnerability measures and only false-positive rates, we refit the models for this outcome adjusting for patient characteristics listed above and for possible mediating facility characteristics. The goal of these fully adjusted models was to assess whether associations between vulnerability and false-positive rates were attenuated by adjusting for facility characteristics. Each of these facility characteristics were added to the model separately because 1 site did not collect profit status (N= 12). Then the facility characteristics were added simultaneously in a separate model as a sensitivity analysis. We reported ORs and 95% CIs for the association between false-positive rates and each of the vulnerability measures, as well as each of the facility characteristics. We also tested for an interaction (a = 0.05) between the 4 vulnerability indexes and the 4 facility characteristics. We then conducted post hoc descriptive analyses of the facilities without ultrasound to characterize these facilities further. Adjusted performance measures were estimated using marginal standardization. 15, 16 Models were fit using SAS software, version 9.2 (SAS Institute Inc., Cary, NC).
RESULTS
Overall 78,733 diagnostic mammography examinations performed among 69,161 women at 139 facilities were included (Table 1 ). Sixty-one percent of all mammography Table 2 ). The majority provided biopsy services (61.2%). Only 10.1% were affiliated with an academic medical center. Of the 91% that reported ownership status, 32.3% were for profit. Facilities serving vulnerable women were more likely to have ultrasound and biopsy services available and were less likely to be for profit.
In analyses unadjusted for patient or facility characteristics, facilities serving vulnerable women tended to have higher false-positive rates across all measures of vulnerability, whereas sensitivity and cancer detection rates did not differ consistently (Table 3 ). After adjusting for patient characteristics only, the differences in false-positive rates remained (P < 0.05 for all vulnerability measures except minority status, P = 0.07). These adjusted ORs comparing the odds of a false positive between facilities on the basis of the binary vulnerability indexes were: lower educational attainment (OR 1.33; 95% CI, 1.03-1.74); racial/ethnic minority status (OR 1.33; 95% CI, 0.98-1.80); rural residence (OR 1.56; 95% CI, 1.26-1.92); limited household income (OR 1.38; 95% CI, 1.10-1.73). In addition, adjusting for facility characteristics (added to the model individually and then simultaneously) did not substantially change these ORs, suggesting that none of these characteristics explained the previously identified relationship between facilities serving vulnerable populations and false-positive rates ( Table 4) .
Although adjusting for facility characteristics did not substantially attenuate the association between vulnerability and false-positive rates, the facility characteristic point estimates from these individual models suggested that availability of on-site ultrasound and biopsy services were associated with greater odds of a false positive ( Table 5 ). Significant ORs (P < 0.05) from these models ranged from 1.68 to 1.88 for on-site ultrasound and 1.24 to 1.30 for biopsy services. However, in the sensitivity analysis adjusting P for trend = 0.10 *Facilities serving vulnerable women include those serving: <83% of the facility population completed high school; >30% of the facility population are minorities; average percentage of rural residences among the facility population is >52%; and average median household income among the facility population is <$45,000.
w Adjusted for study site and patient characteristics: age, time since previous mammogram, and Breast Imaging Reporting and Data System breast density. z Rural residence and income are generated from area-level data. y Composite vulnerability scores were calculated by adding 1 for each of the vulnerability indexes met. The value in bold are statistically significant difference between groups, ie, the confidence intervals did not cross 1.00 or P value was < 0.05. CDR indicates cancer detection rates; CI, confidence interval; OR, odds ratio. for all 4 facility characteristics simultaneously, these ORs were attenuated (ranged from 1.50 to 1.68 for on-site ultrasound and 1.10 to 1.23 for biopsy services, P > 0.05data not shown), though estimated directions were consistent with primary models. Notably, the 10% of facilities without on-site ultrasound also lacked biopsy services. We detected no interaction (on the log-odds scale) between these services and vulnerability indexes (P for interaction >0.05), thus suggesting that facilities with these on-site diagnostic services tended to have higher false-positive rates than those without these services, regardless of the vulnerability of the population served by these facilities.
DISCUSSION
Facilities serving vulnerable women had higher diagnostic mammography false-positive rates than facilities serving primarily nonvulnerable women. These differences were not accounted for by differences in availability of on-site breast ultrasound or biopsy, academic medical affiliation, or profit status, even though the availability of on-site diagnostic services were associated with higher false-positive rates.
Understanding the reasons driving differences in mammography interpretative performance is important to decrease breast cancer disparities and to curb unnecessary health care costs. Prior literature reports the excess costs from false-positive screening mammography of $500 per mammogram. 17 Although specific estimates are not available for the fiscal impact of false positives in diagnostic mammography, likely false-positive diagnostic mammography that leads to unnecessary biopsies are even more costly per abnormal reading, as these lead to excess biopsies, instead of follow-up mammography. 18 As many facilities serving vulnerable women fund their mammography centers through foundation grants aimed at increasing access to screening for uninsured women, 19, 20 false positives particularly can drain these limited resources.
Solutions to decreasing disparities in false-positive rates start by identifying potential causes. Practice patterns of radiologists working at facilities that serve vulnerable women could account for our findings. Radiologists with more recent training (ie, less experienced) and who read comparatively fewer diagnostic mammograms tend to have *Facilities serving vulnerable women include those serving: <83% of the facility population completed high school; >30% of the facility population are minorities; average percentage of rural residences among the facility population is >52%; and average median household income among the facility population is <$45,000.
w Rural residence and income are generated from area-level data.
z Adjusted for study site and patient characteristics: age, time since previous mammogram, and Breast Imaging Reporting and Data System breast density. y Composite vulnerability scores were calculated by adding 1 for each of the vulnerability indexes met. 8 Models with profit status had N = 127 facilities as profit status was not collected from 1 site. The value in bold are statistically significant difference between groups, ie, the confidence intervals did not cross 1.00 or P value was < 0.05. CI indicates confidence interval; OR odds ratio.
higher false-positive rates than other radiologists, 21 and such radiologists may more frequently practice at facilities serving vulnerable populations. Radiologists at these facilities may also recall patients more frequently because of the realization that often cancer prevalence and loss-to-followup rates are higher among women at these facilities. 22 Interventions to recruit highly experienced, fellowship-trained radiologists may help improve diagnostic interpretive performance at these facilities.
Our finding that facilities with on-site diagnostic services have higher false-positive rates is consistent with prior research showing that readily available services may be more readily used. 19 However, this finding may be driven by unmeasured characteristics associated with lack of such services at these facilities.
There are several limitations to this study. Income and rural residence were obtained using ZIP code averages, and insurance data were unavailable. We excluded mammography where breast density was unavailable. This study does not evaluate whether the follow-up rates for recalled mammograms differ by facility type. Although our findings are consistent with previous work that suggests use of ultrasound increases false-positive rates, 20 the prevalence of ultrasound availability is extremely high in our sample, close to 90%. However, availability of ultrasound on-site may not be equated to use in individual women; the BCSC data are unable to consistently ascertain whether a woman actually received ultrasound in this cohort. Our dataset does not capture radiologist characteristics and prior training experience.
Neither on-site breast ultrasound or biopsy, academic medical center affiliation, nor profit status explains the higher diagnostic mammography false-positive rates observed at facilities serving predominantly vulnerable women. Interventions to improve the accuracy of diagnostic mammography interpretations should consider whether the higher false-positive rates are driven by practice patterns of radiologists at these facilities. Realizing that the availability of on-site diagnostic services may contribute to higher utilization of medical care overall, future studies should evaluate the appropriateness of referrals for biopsy in this context. Rural/urban residence and income are generated from area-level data.
z "No ultrasound services" is the referent group. y "No biopsy services" is the referent group. 8 "No academic affiliation" is the referent group. z "Not for profit" is the referent group. # N = 127, as 1 site (N = 12) did not report profit status. The value in bold are statistically significant difference between groups, ie, the confidence intervals did not cross 1.00 or P value was < 0.05. CI indicates confidence interval; OR odds ratio.
